SAN DIEGO, April 10, 2012 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the Company") today announced its intention to offer, subject to market and other conditions, shares of its common stock in an underwritten public offering. TearLab also expects to grant the underwriter a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any. The proceeds of the offering will be used for working capital and general corporate purposes.
